The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 in Children With Henoch-schönlein Purpura
Clinical trial NCT04387942 · COMPLETED
Trial details
- NCT number
- NCT04387942
- Sponsor
- The First Hospital of Jilin University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-14
- Primary completion
- 2022-05-31
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.